Dreyer Scott bought COLL
February 10, 2026 · Form 4 insider transaction
Dreyer Scott bought 30,702 shares of Collegium Pharmaceutical, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,702
Price
$0.00
Total value
N/A
InsiderDreyer Scott
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 10, 2026
Filing dateFebruary 12, 2026
Shares owned after153,338
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 30,702 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.